TY - JOUR
T1 - Assessing the impact of multicomponent interventions on colorectal cancer screening through simulation
T2 - What would it take to reach national screening targets in North Carolina?
AU - Hicklin, Karen
AU - O'Leary, Meghan C.
AU - Nambiar, Siddhartha
AU - Mayorga, Maria E.
AU - Wheeler, Stephanie B.
AU - Davis, Melinda M.
AU - Richardson, Lisa C.
AU - Tangka, Florence K.L.
AU - Lich, Kristen Hassmiller
N1 - Funding Information:
This study was supported, in part, by Cooperative Agreement Numbers U48-DP005017 (PI: Alice Ammerman, DrPH, University of North Carolina at Chapel Hill) and U48-DP005006 (PI: Tom Becker, MD, PhD, Oregon Health & Science University) from the Centers for Disease Control and Prevention (CDC) Prevention Research Centers (PRC) Program and the National Cancer Institute (NCI), as part of the Cancer Prevention and Control Research Network (CPCRN). KH was supported by the NCI -funded T32 Cancer Health Disparities Training Program, University of North Carolina at Chapel Hill (Project#: 2T32CA128582–11, PI: Eugenia Eng, Deborah Tate). MCO was supported by the Cancer Care Quality Training Program, University of North Carolina at Chapel Hill , (Grant No. T32-CA-116339, PI: Ethan Basch, Stephanie Wheeler). MMD was supported by an Agency for Healthcare Research & Quality patient-centered outcomes research (PCOR) K12 award (Award # K12 HS022981 01, PI: Jeanne-Marie Guise) and an NCI K07 award (1K07CA211971-01A1, PI: Davis).
Funding Information:
SBW has received unrelated grant funding in the past three years, paid to her institution from Pfizer. All other authors declare no conflicts of interest.
Publisher Copyright:
© 2022 Elsevier Inc.
PY - 2022/9
Y1 - 2022/9
N2 - Healthy People 2020 and the National Colorectal Cancer Roundtable established colorectal cancer (CRC) screening targets of 70.5% and 80%, respectively. While evidence-based interventions (EBIs) have increased CRC screening, the ability to achieve these targets at the population level remains uncertain. We simulated the impact of multicomponent interventions in North Carolina over 5 years to assess the potential for meeting national screening targets. Each intervention scenario is described as a core EBI with additional components indicated by the “+” symbol: patient navigation for screening colonoscopy (PN-for-Col+), mailed fecal immunochemical testing (MailedFIT+), MailedFIT+ targeted to Medicaid enrollees (MailedFIT + forMd), and provider assessment and feedback (PAF+). Each intervention was simulated with and without Medicaid expansion and at different levels of exposure (i.e., reach) for targeted populations. Outcomes included the percent up-to-date overall and by sociodemographic subgroups and number of CRC cases and deaths averted. Each multicomponent intervention was associated with increased CRC screening and averted both CRC cases and deaths; three had the potential to reach screening targets. PN-for-Col + achieved the 70.5% target with 97% reach after 1 year, and the 80% target with 78% reach after 5 years. MailedFIT+ achieved the 70.5% target with 74% reach after 1 year and 5 years. In the Medicaid population, assuming Medicaid expansion, MailedFIT + forMd reached the 70.5% target after 5 years with 97% reach. This study clarifies the potential for states to reach national CRC screening targets using multicomponent EBIs, but decision-makers also should consider tradeoffs in cost, reach, and ability to reduce disparities when selecting interventions.
AB - Healthy People 2020 and the National Colorectal Cancer Roundtable established colorectal cancer (CRC) screening targets of 70.5% and 80%, respectively. While evidence-based interventions (EBIs) have increased CRC screening, the ability to achieve these targets at the population level remains uncertain. We simulated the impact of multicomponent interventions in North Carolina over 5 years to assess the potential for meeting national screening targets. Each intervention scenario is described as a core EBI with additional components indicated by the “+” symbol: patient navigation for screening colonoscopy (PN-for-Col+), mailed fecal immunochemical testing (MailedFIT+), MailedFIT+ targeted to Medicaid enrollees (MailedFIT + forMd), and provider assessment and feedback (PAF+). Each intervention was simulated with and without Medicaid expansion and at different levels of exposure (i.e., reach) for targeted populations. Outcomes included the percent up-to-date overall and by sociodemographic subgroups and number of CRC cases and deaths averted. Each multicomponent intervention was associated with increased CRC screening and averted both CRC cases and deaths; three had the potential to reach screening targets. PN-for-Col + achieved the 70.5% target with 97% reach after 1 year, and the 80% target with 78% reach after 5 years. MailedFIT+ achieved the 70.5% target with 74% reach after 1 year and 5 years. In the Medicaid population, assuming Medicaid expansion, MailedFIT + forMd reached the 70.5% target after 5 years with 97% reach. This study clarifies the potential for states to reach national CRC screening targets using multicomponent EBIs, but decision-makers also should consider tradeoffs in cost, reach, and ability to reduce disparities when selecting interventions.
KW - Colorectal cancer screening
KW - Modeling
KW - Multicomponent interventions
KW - Population-level outcomes
KW - Simulation
KW - Targets
UR - http://www.scopus.com/inward/record.url?scp=85134983881&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85134983881&partnerID=8YFLogxK
U2 - 10.1016/j.ypmed.2022.107126
DO - 10.1016/j.ypmed.2022.107126
M3 - Article
C2 - 35787844
AN - SCOPUS:85134983881
SN - 0091-7435
VL - 162
JO - Preventive Medicine
JF - Preventive Medicine
M1 - 107126
ER -